Exacta-Med® Oral Dispensers Eliminate Wrong-Route Errors And Inappropriate Clinical Line Connections
Baxa Corporation, a Denver-based manufacturer of medical devices and systems, offers the Exacta-Med Oral Dispenser specifically designed for safe oral liquid delivery. The Exacta-Med Dispenser’s design prevents the attachment of a luer needle hub and from engaging with a needleless connector, eliminating potential error from wrong-route oral liquid medication administration. Additionally, the dispenser is labeled “Oral Use Only,” further promoting patient safety.
Denver, CO, August 31, 2005 --(PR.com)-- Baxa Corporation, a Denver-based manufacturer of medical devices and systems, offers the Exacta-Med Oral Dispenser specifically designed for safe oral liquid delivery. The Exacta-Med Dispenser’s design prevents the attachment of a luer needle hub and from engaging with a needleless connector, eliminating potential error from wrong-route oral liquid medication administration. Additionally, the dispenser is labeled “Oral Use Only,” further promoting patient safety.
“Dosing oral liquid medications with standard luer syringes is unsafe and potentially hazardous because of the risk of wrong-route administration,” says Mark Thrasher, Market Manager for the oral dispenser product line. “The dispenser’s syringe-like design provides convenient and accurate administration—that’s why Exacta-Med Oral Dispensers are the global brand leader. They’re a dependable, safe and exact oral dosing tool for infants and children.”
In the 1970’s, Baxa realized the need to minimize the risk of wrong-route administration. A growing practice was to administer oral medications using hypodermic syringes. Even with an oral label, syringes inadvertently could be used to administer an oral medication into an IV site. Baxa set out to correct these potentially lethal situations.
“I was in a dark Isolette® about to administer medication to an infant when I realized how easy it would be to injure the baby by injecting oral medication into the IV line,” says Lynette Lewis, Clinical Resource Nurse at St. Francis Hospital, Tulsa Oklahoma. “The importance of the Exacta-Med Oral Dispenser became crystal clear to me at that moment.”
Baxa Corporation strives to enhance efficiencies in hospital pharmacies and ultimately improve patient safety. The company recently launched a three-part campaign for its oral dispenser line, aimed at educating pediatric and neonatal nurses on the risks of wrong-route drug administration. The campaign consisted of a letter with a request for dispenser samples as an action step, a complementary advertisement placed in the Journal of Pediatric Health Care and finally a three-dimensional mailer with an oral dispenser inside a custom box. Baxa has traditionally marketed its oral dispensers to hospital pharmacies and response to the nursing campaign have been strong to date.
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Further information is available at www.baxa.com.
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com
“Dosing oral liquid medications with standard luer syringes is unsafe and potentially hazardous because of the risk of wrong-route administration,” says Mark Thrasher, Market Manager for the oral dispenser product line. “The dispenser’s syringe-like design provides convenient and accurate administration—that’s why Exacta-Med Oral Dispensers are the global brand leader. They’re a dependable, safe and exact oral dosing tool for infants and children.”
In the 1970’s, Baxa realized the need to minimize the risk of wrong-route administration. A growing practice was to administer oral medications using hypodermic syringes. Even with an oral label, syringes inadvertently could be used to administer an oral medication into an IV site. Baxa set out to correct these potentially lethal situations.
“I was in a dark Isolette® about to administer medication to an infant when I realized how easy it would be to injure the baby by injecting oral medication into the IV line,” says Lynette Lewis, Clinical Resource Nurse at St. Francis Hospital, Tulsa Oklahoma. “The importance of the Exacta-Med Oral Dispenser became crystal clear to me at that moment.”
Baxa Corporation strives to enhance efficiencies in hospital pharmacies and ultimately improve patient safety. The company recently launched a three-part campaign for its oral dispenser line, aimed at educating pediatric and neonatal nurses on the risks of wrong-route drug administration. The campaign consisted of a letter with a request for dispenser samples as an action step, a complementary advertisement placed in the Journal of Pediatric Health Care and finally a three-dimensional mailer with an oral dispenser inside a custom box. Baxa has traditionally marketed its oral dispensers to hospital pharmacies and response to the nursing campaign have been strong to date.
About Baxa Corporation
Celebrating 30 years of business in 2005, Baxa Corporation is a Denver-based manufacturer of medical devices and systems for preparing, handling, packaging, and administering liquid medications. The company manufactures and markets a wide range of healthcare products for use in hospitals, critical care units and alternate-site pharmacies. Further information is available at www.baxa.com.
###
Contacts:
Marian Robinson, Vice President, Marketing
Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157
Email: marian.robinson@baxa.com
Maggie Chamberlin Holben, APR
Absolutely Public Relations: 303.984.9801 or 303.669.3558
Email: maggie@absolutelypr.com
Contact
Baxa Corporation
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Maggie Chamberlin Holben, APR
303.984.9801 or 303.669.3558
http://www.baxa.com
Contact
Categories